Literature DB >> 19828176

Factor V Leiden as risk factor for unexplained stillbirth--a population-based nested case-control study.

Leena M Hiltunen1, Hannele Laivuori, Anna Rautanen, Risto Kaaja, Juha Kere, Tom Krusius, Mikko Paunio, Vesa Rasi.   

Abstract

INTRODUCTION: Stillbirth is a relatively uncommon pregnancy complication in developed countries yet causing strong emotional burden. Thrombophilia has been associated with stillbirth but population-based studies are few. We assessed selected genetic and acquired parameters for the risk of unexplained stillbirth, including FV Leiden.
MATERIALS AND METHODS: We performed a population-based nested case-control study of 100,000 consecutive pregnancies in Finland. Cases and controls were identified by combining national registers and accepted according to strict criteria after checking their medical records. Stillbirth was defined as intrauterine fetal death > or =22weeks of gestation. We excluded stillbirths due to lethal congenital developmental conditions, umbilical cord complications, and infections. We studied 44 cases of unexplained stillbirth and 766 controls.
RESULTS: FV Leiden was associated with 3.8-fold (95% CI 1.2-11.6) risk for unexplained stillbirth, 3.9-fold (95% CI 1.1-13.9) risk for unexplained late stillbirth (> or =28weeks of gestation), and 10.8-fold (95% CI 2.1-55.3) risk for unexplained stillbirth with placental lesions. The same figures for singleton pregnancies were 3.1-fold (95% CI 0.9-10.9), 4.3-fold (95% CI 1.2-15.3), and 10.6-fold (95% CI 2.1-54.3). Slightly increased risk associated with blood group O was not statistically significant. We found a trend for increased risk in advanced maternal age and smoking during pregnancy. High pre-pregnancy BMI was not associated with increased risk, nor was low educational level or first pregnancy.
CONCLUSIONS: Our population-based study from a country with comprehensive prenatal care confirms the association between FV Leiden and unexplained stillbirth. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828176     DOI: 10.1016/j.thromres.2009.09.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

Review 1.  Perinatal death investigations: What is current practice?

Authors:  J W Nijkamp; N J Sebire; K Bouman; F J Korteweg; J J H M Erwich; S J Gordijn
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-18       Impact factor: 3.926

2.  Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population.

Authors:  Samieh Karimi; Majid Yavarian; Azadeh Azinfar; Minoo Rajaei; Maryam Azizi Kootenaee
Journal:  Iran J Reprod Med       Date:  2012-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.